Wound Care Prescribing FAQ: Allergies, Renal Dosing, and Prior Auth
faq
Answers to the questions clinicians ask most about picking safe, covered antibiotics and topicals for wound care patients.
Common questions about prescribing in wound care — how allergies, renal function, and insurance coverage interact when you're picking an antibiotic or topical at the point of care.
Q: How should allergies be handled in a wound care prescribing workflow?
As hard limits. A documented penicillin or sulfa allergy should silently remove those drug classes from the shortlist, not just warn after the fact. That prevents a well-meaning selection from being reversed at the pharmacy.
Q: What eGFR threshold changes antibiotic choice for a DFU?
Below 60, dose adjustments come into play for TMP-SMX, cephalexin, and levofloxacin. Below 30, avoid nitrofurantoin entirely and reassess vancomycin trough targets. The prescribing surface should flag the eGFR value and the specific monitoring concern.
Q: When is prior authorization worth the delay?
When first-line tier-one options are excluded by allergy, resistance, or documented failure. Amber PA flags on the shortlist tell you the drug is covered if you supply justification, which is different from a hard denial.
Q: Can AI sign a prescription?
No. AI assistance surfaces ranked options and prefills the form; a licensed provider reviews, edits, and signs. Drafts remain drafts until a human acts.
Q: How is coverage information sourced?
From the patient's active plan on file — Medicare Part D, Medicaid MCO, or commercial formulary — refreshed at encounter time so tiering reflects the current year's rules.
Q: What happens when no safe, covered drug exists?
The shortlist collapses to next-best options with clear rationale (e.g., PA required, higher cost tier). At that point the clinician decides between escalation, referral, or IV therapy.
Related reading: AI scribe for wound care and the wound care encounter workflow FAQ.